Pms46 Impact of Etanercept on Work and Activity Impairment in Employed Patients With Moderate to Severe Rheumatoid Arthritis

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.02.731
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Impact of Etanercept Tapering on Work Productivity in Patients With Early Rheumatoid Arthritis: Results From the PRIZE Study

RMD Open
RheumatologyAllergyImmunology
2016English

Impact of Psychological Factors on Subjective Disease Activity Assessments in Patients With Severe Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2014English

Etanercept: Therapeutic Use in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1999English

Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population From a National British Observational Cohort

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Switch From Reference Etanercept to SDZ ETN, an Etanercept Biosimilar, Does Not Impact Efficacy, Safety, and Immunogenicity of Etanercept in Patients With Moderate-To-Severe Rheumatoid Arthritis: 48-Week Results From the Phase III, Randomized, Double-Blind EQUIRA Study

Arthritis Research & Therapy
2019English

Anti-Atherosclerotic Effects of Etanercept in Rheumatoid Arthritis Patients

Japanese Journal of Clinical Immunology
2012English

Pharmacogenetics of Etanercept in Rheumatoid Arthritis

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2008English

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Disability Work Among Argentinean Patients With Rheumatoid Arthritis

Open Journal of Rheumatology and Autoimmune Diseases
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy